NEW YORK, NY / ACCESSWIRE / October 16, 2020 /Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:
American Renal Associates Holdings, Inc. (NYSE:ARA) relating to its acquisition by Nautic Partners, LLC. Under the terms of the agreement, ARA shareholders shall be entitled to receive $11.50 in cash for each share of ARA common stock owned. Click here for more information:https://www.monteverdelaw.com/case/american-renal-associates-holdings-inc. It is free and there is no cost or obligation to you.
MYOS RENS Technology, Inc. (NASDAQ:MYOS) relating to its merger with MedAvail, Inc. Under the terms of the agreement, MYOS shareholders receive a dividend of a MYOS subsidiary, and MYOS shareholders will own only 3.5% of the new combined company. The remaining 96.5% of the new entity will be owned by MedAvail's security holders and new investors. Click here for more information: https://www.monteverdelaw.com/case/myos-rens-technology-inc. It is free and there is no cost or obligation to you.
MyoKardia, Inc. (NASDAQ:MYOK) relating to the merger agreement with Bristol-Myers Squibb Company. Under the terms of the agreement, MyoKardia shareholders shall be entitled to receive $225.00 in cash for each share of MyoKardia common stock owned. Click here for more information:https://www.monteverdelaw.com/case/myokardia-inc. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter
SOURCE: Monteverde & Associates PC
View source version on accesswire.com:
https://www.accesswire.com/610870/SHAREHOLDER-ALERT-Monteverde-Associates-Continues-to-Investigate-the-Following-Merger
